4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis

Detalhes bibliográficos
Autor(a) principal: de Almeida, Ana Carolina [UNESP]
Data de Publicação: 2011
Outros Autores: Marques, Otavio Cabral, Arslanian, Christina, Condino-Neto, Antonio, Ximenes, Valdecir Farias [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.ejphar.2011.03.043
http://hdl.handle.net/11449/8788
Resumo: Apocynin, a methoxy-substituted catechol (4-hydroxy-3-methoxyacetophenone), originally extracted from the roots of Picrorhiza kurroa, has been extensively used as a non-toxic inhibitor of the multienzymatic complex NADPH oxidase. We discovered that the analogous methoxy-substituted catechol, 4-Fluoro-2-methoxyphenol (F-apocynin), in which the acetyl group present in apocynin was changed to a fluorine atom, was significantly more potent as an inhibitor of NADPH oxidase activity, myeloperoxidase (MPO) chlorinating activity and phagocytosis of microorganisms by neutrophils; it was also as potent as apocynin in inhibiting tumor necrosis factor-alpha (TNF alpha) release by peripheral blood mononuclear cells. We attribute the increased potency of F-apocynin to its increased lipophilicity, which could facilitate the passage of the drug through the cell membrane. The inhibition of MPO chlorination activity, phagocytosis and TNF alpha release shows that apocynin and F-apocynin actions are not restricted to reactive oxygen species inhibition, but further studies are needed to clarify if these mechanisms are related. Like apocynin, F-apocynin did not show cell toxicity, and is a strong candidate for use in the treatment of inflammatory diseases. (C) 2011 Elsevier B.V. All rights reserved.
id UNSP_2b270e04a656d92644576e79c365df55
oai_identifier_str oai:repositorio.unesp.br:11449/8788
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosisApocyninNeutrophilMyeloperoxidaseNADPH oxidaseTNF alphaPhagocytosisApocynin, a methoxy-substituted catechol (4-hydroxy-3-methoxyacetophenone), originally extracted from the roots of Picrorhiza kurroa, has been extensively used as a non-toxic inhibitor of the multienzymatic complex NADPH oxidase. We discovered that the analogous methoxy-substituted catechol, 4-Fluoro-2-methoxyphenol (F-apocynin), in which the acetyl group present in apocynin was changed to a fluorine atom, was significantly more potent as an inhibitor of NADPH oxidase activity, myeloperoxidase (MPO) chlorinating activity and phagocytosis of microorganisms by neutrophils; it was also as potent as apocynin in inhibiting tumor necrosis factor-alpha (TNF alpha) release by peripheral blood mononuclear cells. We attribute the increased potency of F-apocynin to its increased lipophilicity, which could facilitate the passage of the drug through the cell membrane. The inhibition of MPO chlorination activity, phagocytosis and TNF alpha release shows that apocynin and F-apocynin actions are not restricted to reactive oxygen species inhibition, but further studies are needed to clarify if these mechanisms are related. Like apocynin, F-apocynin did not show cell toxicity, and is a strong candidate for use in the treatment of inflammatory diseases. (C) 2011 Elsevier B.V. All rights reserved.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Univ Estadual Paulista, UNESP, Fac Ciencias, Dept Quim, Bauru, SP, BrazilUniv São Paulo, Inst Ciencias Biomed, BR-05508000 São Paulo, BrazilUniv Estadual Paulista, UNESP, Fac Ciencias, Dept Quim, Bauru, SP, BrazilFAPESP: 08/53458-6Elsevier B.V.Universidade Estadual Paulista (Unesp)Universidade de São Paulo (USP)de Almeida, Ana Carolina [UNESP]Marques, Otavio CabralArslanian, ChristinaCondino-Neto, AntonioXimenes, Valdecir Farias [UNESP]2014-05-20T13:26:59Z2014-05-20T13:26:59Z2011-06-25info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article445-453application/pdfhttp://dx.doi.org/10.1016/j.ejphar.2011.03.043European Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 660, n. 2-3, p. 445-453, 2011.0014-2999http://hdl.handle.net/11449/878810.1016/j.ejphar.2011.03.043WOS:000291623600028WOS000291623600028.pdf4066413997908572Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengEuropean Journal of Pharmacology3.0401,057info:eu-repo/semantics/openAccess2024-04-29T18:16:45Zoai:repositorio.unesp.br:11449/8788Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T14:20:34.373575Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis
title 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis
spellingShingle 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis
de Almeida, Ana Carolina [UNESP]
Apocynin
Neutrophil
Myeloperoxidase
NADPH oxidase
TNF alpha
Phagocytosis
title_short 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis
title_full 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis
title_fullStr 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis
title_full_unstemmed 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis
title_sort 4-Fluoro-2-methoxyphenol, an apocynin analog with enhanced inhibitory effect on leukocyte oxidant production and phagocytosis
author de Almeida, Ana Carolina [UNESP]
author_facet de Almeida, Ana Carolina [UNESP]
Marques, Otavio Cabral
Arslanian, Christina
Condino-Neto, Antonio
Ximenes, Valdecir Farias [UNESP]
author_role author
author2 Marques, Otavio Cabral
Arslanian, Christina
Condino-Neto, Antonio
Ximenes, Valdecir Farias [UNESP]
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv de Almeida, Ana Carolina [UNESP]
Marques, Otavio Cabral
Arslanian, Christina
Condino-Neto, Antonio
Ximenes, Valdecir Farias [UNESP]
dc.subject.por.fl_str_mv Apocynin
Neutrophil
Myeloperoxidase
NADPH oxidase
TNF alpha
Phagocytosis
topic Apocynin
Neutrophil
Myeloperoxidase
NADPH oxidase
TNF alpha
Phagocytosis
description Apocynin, a methoxy-substituted catechol (4-hydroxy-3-methoxyacetophenone), originally extracted from the roots of Picrorhiza kurroa, has been extensively used as a non-toxic inhibitor of the multienzymatic complex NADPH oxidase. We discovered that the analogous methoxy-substituted catechol, 4-Fluoro-2-methoxyphenol (F-apocynin), in which the acetyl group present in apocynin was changed to a fluorine atom, was significantly more potent as an inhibitor of NADPH oxidase activity, myeloperoxidase (MPO) chlorinating activity and phagocytosis of microorganisms by neutrophils; it was also as potent as apocynin in inhibiting tumor necrosis factor-alpha (TNF alpha) release by peripheral blood mononuclear cells. We attribute the increased potency of F-apocynin to its increased lipophilicity, which could facilitate the passage of the drug through the cell membrane. The inhibition of MPO chlorination activity, phagocytosis and TNF alpha release shows that apocynin and F-apocynin actions are not restricted to reactive oxygen species inhibition, but further studies are needed to clarify if these mechanisms are related. Like apocynin, F-apocynin did not show cell toxicity, and is a strong candidate for use in the treatment of inflammatory diseases. (C) 2011 Elsevier B.V. All rights reserved.
publishDate 2011
dc.date.none.fl_str_mv 2011-06-25
2014-05-20T13:26:59Z
2014-05-20T13:26:59Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.ejphar.2011.03.043
European Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 660, n. 2-3, p. 445-453, 2011.
0014-2999
http://hdl.handle.net/11449/8788
10.1016/j.ejphar.2011.03.043
WOS:000291623600028
WOS000291623600028.pdf
4066413997908572
url http://dx.doi.org/10.1016/j.ejphar.2011.03.043
http://hdl.handle.net/11449/8788
identifier_str_mv European Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 660, n. 2-3, p. 445-453, 2011.
0014-2999
10.1016/j.ejphar.2011.03.043
WOS:000291623600028
WOS000291623600028.pdf
4066413997908572
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv European Journal of Pharmacology
3.040
1,057
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 445-453
application/pdf
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128349807050752